Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study

OBJECTIVE: The purpose of this study was to investigate the use of vaginal progesterone for the prevention of preterm delivery in twin pregnancies. STUDY DESIGN: We conducted a prospective, randomized, doubleblind, placebo-controlled trial that involved 390 naturally conceived twin pregnancies among mothers with no history of preterm delivery who were receiving antenatal care at a single center. Women with twin pregnancies between 18 and 21 weeks and 6 days' gestation were assigned randomly to daily vaginal progesterone (200 mg) or placebo ovules until 34 weeks and 6 days' gestation. The primary outcome was the difference in mean gestational age at delivery; the secondary outcomes were the rate of spontaneous delivery at <34 weeks' gestation and the rate of neonatal composite morbidity and mortality in the treatment and nontreatment groups. RESULTS: The baseline characteristics were similar in both groups. The final analysis included 189 women in the progesterone group and 191 in the placebo group. No difference (P = .095) in the mean gestational age at delivery was observed between progesterone (35.08 +/- 3.19 [SD]) and placebo groups (35.55 +/- 2.85). The incidence of spontaneous delivery at <34 weeks' gestation was 18.5% in the progesterone group and 14.6% in the placebo group (odds ratio, 1.32; 95% confidence interval, 0.24-2.37). No difference in the composite neonatal morbidity and mortality was observed between the progesterone (15.5%) and placebo (15.9%) groups (odds ratio, 1.01; 95% confidence interval, 0.58-1.75). CONCLUSION: In nonselected twin pregnancies, vaginal progesterone administration does not prevent preterm delivery and does not reduce neonatal morbidity and death.

Palavras-chave

preterm birth, preterm delivery, prevention, progesterone, twin pregnancy

URI

https://observatorio.fm.usp.br/handle/OPI/11733

Referências

Aboulghar MM, 2012, REPROD BIOMED ONLINE, V25, P133, DOI 10.1016/j.rbmo.2012.03.013
Briery CM, 2009, SOUTH MED J, V102, P900, DOI 10.1097/SMJ.0b013e3181afee12
Cetingoz E, 2011, ARCH GYNECOL OBSTET, V283, P423, DOI 10.1007/s00404-009-1351-2
Chauhan SP, 2010, AM J OBSTET GYNECOL, V203, P305, DOI 10.1016/j.ajog.2010.04.031
Combs CA, 2011, AM J OBSTET GYNECOL, V204
Conde-Agudelo A, 2014, AM J OBSTET GYNECOL, V211, P583, DOI 10.1016/j.ajog.2014.07.047
da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41
Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815
Fujita MM, 2002, ACTA OBSTET GYN SCAN, V81, P856, DOI 10.1034/j.1600-0412.2002.810910.x
Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017
Hosmer DW, 2008, APPL SURVIVAL ANAL R, P169
Martin Joyce A, 2011, Natl Vital Stat Rep, V60, P1
Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8
Norusis MJ, 2012, IBM SPSS STAT 19 ADV, P287
Rode L, 2011, ULTRASOUND OBST GYN, V38, P272, DOI 10.1002/uog.9093
Romero R, 2012, AM J OBSTET GYNECOL, V206
Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641
Schuit E, 2015, BJOG-INT J OBSTET GY, V122, P27, DOI 10.1111/1471-0528.13032
Senat MV, 2013, AM J OBSTET GYNECOL, V208
Serra V, 2013, BJOG-INT J OBSTET GY, V120, P50, DOI 10.1111/j.1471-0528.2012.03448.x
Wood S, 2012, J PERINAT MED, V40, P593, DOI 10.1515/jpm-2012-0057

Coleções

Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/36
Artigos e Materiais de Revistas Científicas - LIM/57
Artigos e Materiais de Revistas Científicas - ODS/03

Página do item completo